Schedule 13G ownership disclosure

Cipher Pharmaceuticals Inc

Security class unavailable · CUSIP: 17253X105

Event date: 2015-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
9,731,140
Percent of class
37.2000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-16-096679
Form type
SC 13G
Filer
1207407 Ontario Ltd.
CIK
CIK 1666831
Filed
Feb 12, 2016
Reporting period
Dec 31, 2015
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub

SC 13G | SEC Filings Hub